Richard D. Klausner M.D.
Net Worth
Last updated:
What is Richard D. Klausner M.D. net worth?
The estimated net worth of Dr. Richard D. Klausner M.D. is at least $14,574,756 as of 15 Aug 2023. He owns shares worth $10,081,430 as insider, has earned $203,326 from insider trading and has received compensation worth at least $4,290,000 in Lyell Immunopharma, Inc..
What is the salary of Richard D. Klausner M.D.?
Dr. Richard D. Klausner M.D. salary is $1,430,000 per year as Executive Chairman in Lyell Immunopharma, Inc..
How old is Richard D. Klausner M.D.?
Dr. Richard D. Klausner M.D. is 73 years old, born in 1952.
What stocks does Richard D. Klausner M.D. currently own?
As insider, Dr. Richard D. Klausner M.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | Executive Chairman | 930,880 | $10.83 | $10,081,430 |
What does Lyell Immunopharma, Inc. do?
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications. The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Richard D. Klausner M.D. insider trading
Lyell Immunopharma, Inc.
Dr. Richard D. Klausner M.D. has made 2 insider trades between 2022-2023, according to the Form 4 filled with the SEC. Most recently he sold 58,020 units of LYEL stock worth $132,286 on 15 Aug 2023.
The largest trade he's ever made was exercising 58,020 units of LYEL stock on 15 Aug 2023. As of 15 Aug 2023 he still owns at least 930,880 units of LYEL stock.
Lyell Immunopharma key executives
Lyell Immunopharma, Inc. executives and other stock owners filed with the SEC:
- Dr. Richard D. Klausner M.D. (73) Executive Chairman
- Mr. Stephen J. Hill (55) Chief Operating Officer
- Ms. Elizabeth Homans (59) Chief Executive Officer & Director
- Ms. Heather D. Turner (52) Chief Gen. Counsel & Sec.